Loading…
Loading…
The Aberdeen India Fund, Inc. operates as a closed-end investment vehicle focused on equities, with its management entrusted to Aberdeen Standard Investments (Asia) Limited. This fund primarily directs its capital towards India's publicly traded stock markets, seeking out investment opportunities in companies across the entire market capitalization spectrum, including small, mid, and large-sized enterprises. Its investment methodology combines rigorous quantitative analysis with in-depth fundamental research, adopting a bottom-up stock selection process and strategic asset allocation to build…
Is IFN's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
India Fund, Inc. (NYSE: IFN - Get Free Report) passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $11.41 and traded as low as $10.40. India Fund shares last traded at $10.5160, with a volume of 212,230 shares trading hands. India Fund Trading Down 0.5% The business
JADE301 is designed to build on a clinically validated IFN-β mechanism with a differentiated profile designed for infrequent subcutaneous dosing JADE301 demonstrated high-affinity, selective IFN-β binding and greater functional potency than a dazukibart comparator in disease-relevant human cells Following subcutaneous administration in non-human primates, JADE301 was effectively half-life extended with an approximately 25-day half-life and predictable distribution into muscle JADE301 was well tolerated in non-human primates at all evaluated subcutaneous doses Phase 1 healthy volunteer trial expected to begin in the fourth quarter of 2026; interim data anticipated in the second half of 2027 Company to host conference call and webcast today at 8:30 a.m. ET SAN FRANCISCO and VANCOUVER, British Columbia, Sept.
PHILADELPHIA, Aug. 11, 2026 /PRNewswire/ -- The following abrdn U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, MFM, MGF, MIN, MMT, THQ, THW and NYSE American: FAX, IAF), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on August 31, 2026 to all shareholders of record as of August 24, 2026 (ex-dividend date August 24, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on September 30, 2026, to shareholders of record as of August 24, 2026 (ex‑dividend date August 24, 2026).
Aberdeen India Fund, a CEF that focuses on around 50 Indian stocks, has faced a rough 15 months, but I am prepared to turn cautiously optimistic on it now. Renewed foreign portfolio inflows, regulatory reforms, a wider-than-normal 9.5% discount to NAV, and a boost in its managed distribution policy all enhance the bull case. The risk-reward on the long-term charts too looks enticing, with IFN showing some signs of stabilization in recent months.
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend date May 21, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on June 30, 2026, to shareholders of record as of May 21, 2026 (ex‑dividend date May 21, 2026).